BTTX (Better Therapeutics) FCF Margin %: 0.00% (As of Sep. 2023)


What is Better Therapeutics FCF Margin %?

Better Therapeutics BTTX FCF Margin % is 0.00% as of Sep. 2023.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Better Therapeutics's Free Cash Flow for the three months ended in Sep. 2023 was $-5.88 Mil. Better Therapeutics's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Better Therapeutics's FCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

As of today, Better Therapeutics's current FCF Yield % is -255,300.00%.

The historical rank and industry rank for Better Therapeutics's FCF Margin % or its related term are showing as below:


BTTX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Better Therapeutics FCF Margin % Related Terms

Better Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Better Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Better Therapeutics FCF Margin % Chart

Better Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22
FCF Margin %
-49,738.89 -100,987.50 0.00 0.00

Better Therapeutics Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BTTX vs CYCN, CELZ, NRSN: FCF Margin % Comparison

For the Biotechnology subindustry, Better Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Better Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Better Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Better Therapeutics's FCF Margin % falls into.


Better Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Better Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-30.11/0
= %

Better Therapeutics's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-5.877/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Better Therapeutics (BTTX) has a FCF Margin % of 0.00% as of Sep. 2023. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Better Therapeutics and its competitors.
Is Better Therapeutics' FCF Margin % too high?
Better Therapeutics' current FCF Margin % is 0.00%.
How does Better Therapeutics' FCF Margin % compare to CYCN and CELZ?
Better Therapeutics' FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Better Therapeutics and its competitors. Better Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Better Therapeutics stock overvalued right now?
Better Therapeutics (BTTX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Better Therapeutics (BTTX), the current FCF Margin % is 0.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Better Therapeutics Business Description

Address 548 Market Street, Suite 49404, San Francisco, CA, USA, 94104
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.